ALNY - Alnylam Pharmaceuticals Stock Trading

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2021 on Tuesday, August 3, 2021, before the U.S. financial markets open. Management will provide an u...

Shares of Alnylam (NASDAQ: ALNY) recently dipped after Intellia (NASDAQ: NTLA) stole the spotlight with trial results for a revolutionary new gene therapy that could compete with Onpattro, Alnylam's top drug at the moment. It does look like Onpattro could be in for some ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’ve never bought a biotech stock before, I don’t blame you. When I made my first-ever biotech bet in my early 20s, things turned out as you might expect: Source: Shutterstock The company declared ...